Serina Therapeutics, Inc.
SER
$3.79
-$0.02-0.53%
AMEX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -18.59M | -12.59M | -939.00K | -11.14M | -7.35M |
| Total Depreciation and Amortization | 105.00K | 145.00K | 186.00K | 194.00K | 144.00K |
| Total Amortization of Deferred Charges | 8.00K | 16.00K | 323.00K | 345.00K | 337.00K |
| Total Other Non-Cash Items | -423.00K | -5.29M | -16.06M | -3.22M | -2.16M |
| Change in Net Operating Assets | 2.39M | 2.10M | -3.40M | -3.32M | -3.39M |
| Cash from Operations | -16.51M | -15.62M | -19.88M | -17.14M | -12.43M |
| Capital Expenditure | -64.00K | -54.00K | -8.00K | -22.00K | -87.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -64.00K | -54.00K | -8.00K | -22.00K | -87.00K |
| Total Debt Issued | 5.02M | 118.00K | 643.00K | 3.04M | 2.93M |
| Total Debt Repaid | -1.00K | -9.00K | -155.00K | -168.00K | -180.00K |
| Issuance of Common Stock | 7.08M | 5.64M | 10.00M | 10.00M | 5.08M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 4.94M | 4.94M | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 4.92M | 4.92M | 4.92M | 337.00K | 337.00K |
| Cash from Financing | 21.96M | 15.60M | 15.40M | 13.21M | 8.17M |
| Foreign Exchange rate Adjustments | -2.00K | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 5.39M | -73.00K | -4.49M | -3.95M | -4.35M |